Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

We're celebrating Cyber Weekend with 20% off. Use code cyber2023 at checkout. Shop Now.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Drug Information
  4. Charts

Charts

  • Cannabinoids (17)
  • Charts (563)
    • Disease-Related Charts (480)
    • Practice-Related Charts (200)
  • Combinations (18)
  • Devices (96)
  • Effervescent Products (9)
  • Fluids (5)
  • Formulary/Drug Comparison (462)
  • Injectables (64)
  • MedGuides (514)
  • Nebulizers (13)
  • Needles & Syringes (11)
  • Phosphate (4)
  • Potassium (6)
  • Pumps (6)
  • Salt Forms (8)
  • Specialty Meds (50)
  • Statistics (17)
  • Topicals (34)
496 - 510 of 563 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Chart: Comparison of Antiemetics November 2008
Commentary: Removal of Unapproved Topical Papain-containing Products from the Market November 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Commentary: Rhabdomyolysis with Combined Use of Amiodarone and Simvastatin October 2008
Commentary: New Formulation: Alvesco (Ciclesonide Inhalation Aerosol) September 2008
Chart: New Formulations of Old Drugs September 2008
Guideline: Treating Tobacco Use and Dependence: 2008 Update July 2008
Commentary: Omnaris (Ciclesonide) and Patanase (Olopatadine): New Nasal Sprays for Allergic Rhinitis June 2008
Article: misconceptions about grapefruit juice interactions May 2008
Commentary: Time-release Generic Products:
Are They Equivalent To the Brand Product?
May 2008
Commentary: Pristiq (Desvenlafaxine) May 2008
Chart: Drugs to Avoid in Patients with Dementia May 2008
Commentary: Efficacy of Dementia Drugs and Guidelines for Use May 2008
  • « Prev
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved